Clinical Trial Update: Impact of Prisma on Donor Site Pain [NA]

View source ↗

Summary

Completed clinical trial evaluating the impact of Prisma on donor site pain in skin graft procedures; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Donor Site Complications
• Skin Graft Failure

Drugs mentioned

• Prisma (mesoglycan)

Snippet

Sponsor: NYU Langone Health | Conditions: Skin Graft Disorder, Donor Site Complication | NA | Status: COMPLETED | Results posted: 2024-04-16